Clinicopathological correlation showed that the overexpressed PITX2 was remarkably associated with high-grade (grade 3) (P = 0.023) and clear cell subtype ovarian cancer (P = 0.011) (Table 1). This evidence concerns the gene PITX2 and ovarian carcinoma.